Savencia : actions et droits de vote - information mensuelle Actions et droits de vote – information mensuelle Au 30 septembre 2024, le capital social se composait de 14 032 930 actions représentant un nombre total de droits de vote théoriques de 23 838 961 et un nombre total de droits de vote nets de 23 167 646. Pièce jointe
Savencia : actions et droits de vote - information mensuelle Actions et droits de vote – information mensuelle Au 31 août 2024, le capital social se composait de 14 032 930 actions représentant un nombre total de droits de vote théoriques de 23 837 866 et un nombre total de droits de vote nets de 23 166 255. Pièce jointe
>The price effects offset the decline in the volume mix for cheese products - The stability in sales for cheese products in 9M reflects a volume decline of around 1% (-1.7% in Q3 on our calculations) which is offset by the tariff hikes obtained during the period for most markets. The volume decline in due mainly to Europe (decline at a low figure) while volumes are growing in other regions such as the Americans and Asia excluding China. In Europe, the decline in consu...
>Les effets prix compensent la baisse du mix volume pour les Produits Fromagers - La stabilité du CA des Produits fromagers sur les 9 mois reflète une baisse des volumes de l’ordre de 1% ( -1.7% au T3 selon nos calculs) qui est compensée par les hausses tarifaires obtenues pendant la période sur la plupart des marchés. Le retrait des volumes est principalement lié à l’Europe (baisse à un chiffre bas) alors que les volumes croissent sur les autres zones comme les Améri...
>Organic growth of 2.2% vs 1.5%e, implying a 5.1% increase (vs 2.9%e) in Q3. Activity continues to be driven by other dairy products - Savencia’s 9M sales were close to 1% above our forecasts at € 5,082m, while we had forecast € 5,032m. Sales were up 1.3% and forecast in a negative forex impact of 2.2% partly offset by a scope effect of 1.3% (integration of Williner since April 2023). In organic terms, sales were up 2.2%.vs 1.5%e and 0.8% in H1, implying orga...
>Une croissance organique de 2.2% vs 1.5%e impliquant une hausse de 5.1% (vs 2.9%e) au T3. L’activité reste tirée par les Autres Produits Laitiers - Le CA 9M de Savencia près de 1% au-dessus de nos prévisions à 5 082 M€ alors que nous attendions 5 032 M€. Les ventes progressent de 1.3% et tiennent compte d’un impact changes négatif de 2.2%, partiellement compensé par un effet périmètre de 1.3% (intégration de Williner depuis avril 2023). En organique, le CA pr...
SAVENCIA: Activity at the end of September 2024 Thursday, October 24, 2024 Press Release: activity at the end of September 2024 Sales growth of 1.3% Key figures in €M 30/09/24 % of sales 30/09/23 % of sales % changesTotalStructureChange & IAS 29Organic growth (1)Sales5,082 5,017 1.31.3-2.22.2- Cheese Products2,87956.72,90557.9-0.90.0-1.00.1- Others Dairy Products2,38046.82,27245.34.82.9-4.05.9- Unallocated -178-3.5-159-3.211.50.1-4.816.2 Savencia Fromage & Dairy Group's sales as of September 30, 2024, increased by 1.3% from last year. Despite an unfavorable exchange rate effect o...
SAVENCIA : Activité à fin septembre 2024 Jeudi 24 octobre 2024 Communiqué de Presse : Activité à fin septembre 2024 Progression du chiffre d’affaires de 1,3% Chiffres clés en M€ 30/09/24 % CA 30/09/23 % CA Variations en %TotalStructureChange & IAS 29CroissanceOrganique (1)Chiffre d’affaires5 082 5 017 1,31,3-2,22,2- Produits Fromagers2 87956,72 90557,9-0,90,0-1,00,1- Autres Produits Laitiers2 38046,82 27245,34,82,9-4,05,9- Non Affectés -178-3,5-159-3,211,50,1-4,816,2 Le chiffre d'affaires du Groupe Savencia Fromage & Dairy au 30 septembre 2024 a progressé de 1,3% par rapport à l'...
CF Alba, the March family holding company, invests in listed and unlisted companies where it identifies strong potential, regardless of the investment horizon. Since 1993, it has achieved a total annualized shareholder return of +11%, beating the EuroStoxx index by 3pp. The company currently trades at a c.50% discount to its NAV which is close to its historical maximum. We initiate coverage with an Outperform rating and a target price of € 68, representing a discount to its NAV of 35...
CF Alba, the March family holding company, invests in listed and unlisted companies where it identifies strong potential, regardless of the investment horizon. Since 1993, it has achieved a total annualized shareholder return of +11%, beating the EuroStoxx index by 3pp. The company currently trades at a c.50% discount to its NAV which is close to its historical maximum. We initiate coverage with an Outperform rating and a target price of € 68, representing a discount to its NAV of 35...
>Margin improvement in H1 of close to 130bp for cheese product division - Flat organic growth in the cheese product division in H1 (+0.2%) reflects a slightly negative volume mix (-0.4%e) and positive price mix. Volumes in H1 were underpinned by good sales momentum, particularly in LATAM and a degree of resilience in some western European countries despite anaemic consumption geared more towards private labels and discount prices which seems to have taken more of a to...
>Progression de la marge au S1 de près de 130pb de la division Produits fromagers - La stabilité de la croissance organique du pôle Produits fromagers au S1 (+0.2%) reflète un mix volume légèrement négatif (-0.4%e) et un effet prix positif. Les volumes du S1 sont soutenus par la bonne dynamique de l’activité notamment au LATAM ainsi qu’une certaine résilience de certains pays de l’Europe de l’Ouest malgré une consommation atone, orientée vers les marques de distribute...
Tubacex is a solutions provider for the energy and mobility sectors through high value-added products (seamless stainless-steel tubes) and services. It has recently completed a successful transformation which should result in a much more stable results and cash flow profile going forward (EBITDA margin c.15% vs 10-year historical average of 9%) although 2024 will be a transition year ahead of the completion of the ADNOC contract and the closing of Mubadala’s transaction (acquisition o...
>Organic growth in line at +0.8% buoyed by other dairy products. A 30bp deterioration in the underlying operating margin to 3% vs 3.3% est. - H1 sales published by Savencia yesterday were in line with our forecast at € 3,380m and more or less stable vs H1 2023. Organic growth was 0.8% in line and underpinned by the other dairy products division. The scope effect linked to the integration of Williner was 1.9% and the forex effect was -2.6%, primarily due to the devalua...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.